Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novel naturally produced compound is selective against H. pylori

April 5, 2001

Nonopioid DOP agonists presented at ACS meeting by Pfizer group

April 4, 2001

Health Canada approves Pantoloc for treatment of heartburn

April 3, 2001

HGS initiates phase I trial of Albuferon as treatment for HCV

April 2, 2001

FDA grants priority review status for Entocort modified-release capsules

April 2, 2001

PEG-Intron/Rebetol combination for hepatitis C treatment approved in E.U.

March 30, 2001

Mechanism of gastroprokinetic effects of Z-338 discussed at recent scientific meeting

March 29, 2001

Intravenous formulation of Protonix approved by FDA for GERD

March 29, 2001

TAK-637 effective against the diarrhea and pain characteristic of IBS

March 27, 2001

Schering-Plough receives notification of priority review status for PEG-Intron/Rebetol sBLA

March 27, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...